Amine Functional Polyamides
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/US2014/025384, filed Mar 13, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,682,975 | Method of Preparing Glucosylceramide Synthase Inhibitors In force · High confidence | Genzyme Corporation | In force | High confidence | ||
| US 10,065,949 | Method of Preparing Glucosylceramide Synthase Inhibitors In force · High confidence | Genzyme Corporation | In force | High confidence | ||
| US 10,604,518 | Method of Preparing Glucosylceramide Synthase Inhibitors In force · High confidence | Genzyme Corporation | In force | High confidence | ||
| US 10,954,230 | Method of Preparing Glucosylceramide Synthase Inhibitors In force · High confidence | Genzyme Corporation | In force | High confidence | ||
| US 9,326,994 | Amine Functional Polyamides In force · High confidence | Genzyme Corporation | In force | High confidence | ||
| US 9,518,049 | Salt Forms of (S)-QUINUCLIDIN-3-YL (2-(2-(4-Fluorophenyl)THIAZOL-4-YL)PROPAN-2-YL)CARBAMATE In force · High confidence | Genzyme Corporation | In force | High confidence | ||
| US 10,028,731 | Barrier Application Device In force · High confidence | Baxter International Inc. and Baxter Healthcare S.A. | In force | High confidence | ||
| US 10,113,032 | Amine Functional Polyamides Lapsed Oct 30, 2026 on the fee record Low confidence | Genzyme Corporation | Lapsed Oct 30, 2026 on the fee record | Low confidence | ||
| Application 14/776,059 | Sequestrants of Advanced Glycation End Product (AGE) Precursors Abandoned Abandoned Jan 22, 2018 | Genzyme Corporation | Abandoned | Abandoned Jan 22, 2018 | ||
| Application 15/038,185 | Novel Methods for Treating Neurodegenerative Diseases Abandoned Abandoned Oct 28, 2017 | Genzyme Corporation | Abandoned | Abandoned Oct 28, 2017 | ||
| 4 more patents in this group · Pro | ||||||
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14, including 1 expired.
6 of these are in force and held by Genzyme Corporation.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.